Lifeng Li
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 17
- Cancer, Hypoxia, and Metabolism 11
- Molecular Medicine top 2%
- Immunology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 16
-
- RNA modifications and cancer 23
- Advanced biosensing and bioanalysis techniques 12
- Epigenetics and DNA Methylation 12
-
- Ferroptosis and cancer prognosis 21
-
- Metal-Organic Frameworks: Synthesis and Applications 13
- Journals
- Scientific Reports (7 papers)Medicine (6 papers)Cellular Physiology and Biochemistry (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lifeng Li
251 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 192
- Cancer Research 718
- Molecular Medicine 221
- Immunology 704
- Oncology 857
- Applied Microbiology and Biotechnology 60
Countries citing papers authored by Lifeng Li
This map shows the geographic impact of Lifeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Li more than expected).
Fields of papers citing papers by Lifeng Li
This network shows the impact of papers produced by Lifeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Li. The network helps show where Lifeng Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lifeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 11 | |
| 15 | 2023 | 8 | |
| 16 | 2023 | 15 | |
| 17 | 2023 | 31 | |
| 18 | 2021 | 13 | |
| 19 | 2021 | 8 | |
| 20 | 2012 | 4 |
About Lifeng Li
Lifeng Li is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 273 papers that have together received 5.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (23 papers), Ferroptosis and cancer prognosis (21 papers), Cancer-related molecular mechanisms research (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Metal-Organic Frameworks: Synthesis and Applications (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Epigenetics and DNA Methylation (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). The work is most often cited by research in Cancer Research (718 citations), Molecular Medicine (221 citations) and Immunology (704 citations). Lifeng Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jie Zhao, Wenhua Xue, Zhibo Shen, Yi Zhang, Wancun Zhang, Zhirui Fan, Xinwei Han, Chaoqi Zhang, Xianfei Ding and Liping Wang. Their work appears in journals such as Scientific Reports, Medicine, Cellular Physiology and Biochemistry, Oncotarget and Frontiers in Molecular Biosciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.